This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Bidding for Hertz: Leveraged Buyout - Teaching Note
Chaplinsky, Susan; Marston, Felicia C.Teaching Note DARDEN-F-1560TN-EFinanceTeaching note for product F-1560Starting at €0.00
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
DuPont Corporation: Sale of Performance Coatings
Chaplinsky, Susan; Marston, Felicia C.; Merker, BrettCase DARDEN-F-1709-EFinanceIn January 2012, Ellen Kullman, CEO and chairman of DuPont, must decide whether to retain or sell the company’s Performance Coatings (DPC) division. This is an introductory case on valuing a leveraged buyout. The case focuses on a publicly listed corporation’s decision to divest a large division and asks students to compare the division’s value if it remains under DuPont’s control or is sold to an outside party. The transaction size of approximat...Starting at €8.20
-
Cengage Learning: Can Apax Partners Salvage This Buyout?
Chaplinsky, Susan; Marston, Felicia C.; Smith, David C.Case DARDEN-F-1727-EFinanceThis case investigates the issues involved in a private equity (PE) firm’s decision to invest in the debt of a distressed leveraged buyout. The analysis has been purposefully simplified to involve only two classes of outstanding debt, senior debt and junior debt, so that students do not need to have detailed knowledge of the bankruptcy process to complete the analysis. The main analytical task requires students to compute the expected internal ra...Starting at €8.20
-
Investing in Sponsor-Backed IPOs: The Case of Hertz - Teaching Note
Chaplinsky, Susan; Marston, Felicia C.Teaching Note DARDEN-F-1561TN-EFinanceTeaching note for product F-1561Starting at €0.00
-
The Carlyle Group: IPO of a Publicly Traded Private Equity Firm - Teaching Note
Chaplinsky, Susan; Marston, Felicia C.Teaching Note DARDEN-F-1689TN-EFinanceTeaching note for product F-1689Starting at €0.00
-
Investing in Sponsor-Backed IPOs: The Case of Hertz
Chaplinsky, Susan; Marston, Felicia C.; Pozzi, MichaelCase DARDEN-F-1561-EFinanceThis case and its companion, UVA-F-1560, were awarded the 2012 Wachovia Award for Excellence in Teaching Materials - Innovative Case. In November 2006, Alec Berg, a successful hedge fund manager, must decide whether to invest in the initial public offering (IPO) of the Hertz Corporation. The IPO followed a leveraged buyout (LBO) of Hertz that was completed in December 2005 by three prominent private equity firms that had combined to purchase Hert...Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20